Home/Filings/4/0001415889-25-007073
4//SEC Filing

Jalota Deepika 4

Accession 0001415889-25-007073

CIK 0001699382other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 6:32 PM ET

Size

6.4 KB

Accession

0001415889-25-007073

Insider Transaction Report

Form 4
Period: 2025-03-03
Jalota Deepika
Chief Development Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-03-03+300,000300,000 total
    Exercise: $1.32Exp: 2035-03-03Common Stock (300,000 underlying)
Holdings
  • Common Stock

    123,024
Footnotes (2)
  • [F1]Includes 4,741 shares acquired under the Issuer's Employee Stock Purchase Plan as follows: 2,276 shares acquired on May 20, 2021; 359 shares acquired on November 19, 2021; 993 shares acquired on May 20, 2022 and 1,113 shares acquired on November 21, 2022.
  • [F2]Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025.

Issuer

PMV Pharmaceuticals, Inc.

CIK 0001699382

Entity typeother

Related Parties

1
  • filerCIK 0001825192

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:32 PM ET
Size
6.4 KB